This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Valneva SE's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €1.096. Valneva SE's 10-Year median PS Ratio is 2.8102. Therefore, the Median PS Value for today is €3.08.
As of today (2024-05-16), Valneva SE's share price is €4.056. Valneva SE's Median PS Value is €3.08. Therefore, Valneva SE's Price to Median PS Value for today is 1.32.
The historical rank and industry rank for Valneva SE's Median PS Value or its related term are showing as below:
XPAR:VLA'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.3 Med: 0.8 Max: 1.52
Current: 1.32
During the past 13 years, the highest Price to Median PS Value of Valneva SE was 1.52. The lowest was 0.30. And the median was 0.80.
XPAR:VLA's Price-to-Median-PS-Value is ranked worse than 77.78% of 261
companies
in the Biotechnology industry
Industry Median: 0.7
vs XPAR:VLA: 1.32
Valneva SE Median PS Value Historical Data
The historical data trend for Valneva SE's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Valneva SE's Median PS Value
For the Biotechnology subindustry, Valneva SE's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valneva SE's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Valneva SE's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Valneva SE's Price-to-Median-PS-Value falls into.
Valneva SE Median PS Value Calculation
Valneva SE's Median PS Value for today is calculated as
10-Year Median PS Ratio is 2.8102.
Valneva SE's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.096.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valneva SE (XPAR:VLA) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Valneva SE's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
4.056
/
3.08
=
1.32
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valneva SE Median PS Value Related Terms
Thank you for viewing the detailed overview of Valneva SE's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, & third-party products; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The majority is from the Commercialized vaccines segment & geographically from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:VLA has been successfully added to your 